Raghav KPS, Guthrie KA, Tan B Jr, Denlinger CS, et al. Trastuzumab Plus Pertuzumab Versus Cetuximab Plus Irinotecan in Patients With RAS/BRAF Wild-Type, HER2-Positive, Metastatic Colorectal Cancer (S1613): A Randomized Phase II Trial. J Clin Oncol 2025 Jan 6:JCO2401710. doi: 10.1200/JCO-24-01710.
PMID: 39761503